Cargando…
Structures of synthetic nanobody–SARS-CoV-2 receptor-binding domain complexes reveal distinct sites of interaction
Combating the worldwide spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the emergence of new variants demands understanding of the structural basis of the interaction of antibodies with the SARS-CoV-2 receptor-binding domain (RBD). Here, we report five X-ray crystal struct...
Autores principales: | Ahmad, Javeed, Jiang, Jiansheng, Boyd, Lisa F., Zeher, Allison, Huang, Rick, Xia, Di, Natarajan, Kannan, Margulies, David H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444450/ https://www.ncbi.nlm.nih.gov/pubmed/34537245 http://dx.doi.org/10.1016/j.jbc.2021.101202 |
Ejemplares similares
-
Structures of synthetic nanobody–SARS-CoV-2–RBD complexes reveal distinct sites of interaction and recognition of variants
por: Ahmad, Javeed, et al.
Publicado: (2021) -
Synthetic nanobody–SARS-CoV-2 receptor-binding domain structures identify distinct epitopes
por: Ahmad, Javeed, et al.
Publicado: (2021) -
SARS-CoV-2 antibodies recognize 23 distinct epitopic sites on the receptor binding domain
por: Jiang, Jiansheng, et al.
Publicado: (2023) -
SARS-CoV-2 antibodies recognize 23 distinct epitopic sites on the receptor binding domain
por: Jiang, Jiansheng, et al.
Publicado: (2023) -
Chaperone function in antigen presentation by MHC class I molecules—tapasin in the PLC and TAPBPR beyond
por: Margulies, David H., et al.
Publicado: (2023)